T1	Participants 779 842	Interferon alpha monotherapy relapsers with chronic hepatitis C
T2	Participants 90 153	interferon alpha monotherapy relapsers with chronic hepatitis C
T3	Participants 712 769	interferon monotherapy relapsers with chronic hepatitis C
T4	Participants 1181 1247	Only patients with negative HCV RNA at week 10 continued treatment
T5	Participants 1308 1452	Thirty-seven patients were enrolled, 19 (6 females, median age 43) in the 24 week and 18 (5 females, median age 40) in the 48 week treatment arm
T6	Participants 1841 1948	Three patients discontinued treatment early (two due to moderate adverse events, one due to non-compliance)
T7	Participants 2372 2406	relapsers with chronic hepatitis C
